By Madeleine Benn Staff Writer Central Coast hospitals and health care facilities are straining to care for patients suffering from RSV, a contagious, potentially serious, non-COVID-19 illness that could combine with COVID and other infectious diseases to result in a multi-epidemic in the region during the winter months, say local public health officials, health care Read More →
Thousand Oaks biotech giant posts solid results By Jorge Mercado Senior Staff Writer Thousand Oaks-based Amgen’s shares have soared to record highs, even as competitors’ stocks have been hammered by the bull market. Amgen, one of the world’s largest biotechnology companies, has been up about 25% year to date, compared to a loss of 29% Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks-based Amgen saw a slight decline in revenue for the third quarter of 2022, but a substantial increase in earnings helped the company beat analysts’ expectations and maintain its stock price. One of the largest biotechnology companies in the world, Amgen delivered net income of $2.1 billion, or $3.98 per share, in the third Read More →